CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 41 enrolled
Drug / intervention
Inmunoferon +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06249620
NCT06249620N/ACompleted

A Randomized Controlled Trial of Oral Suplementation With AM3, Hesperidin and Spermidine on Immunity Response and Biological Age in Healthy Volunteers.

Industrial Farmacéutica Cantabria, S.A.·interventional·Posted Feb 8, 2024·Updated Feb 8, 2024

In Brief

A clinical study evaluating Inmunoferon and Placebo for Healthy. Completed, enrolled 41 participants across 1 site.

Detailed Summary

The goal of this interventional study is to know the immune status of healthy participants and to obtain their biological age before and after two months of ingesting a dietary supplement. These individuals are compared with others who will be given a product of similar appearance, but without containing active components, being the constituents of the placebo group. The study has a duration of 8 weeks, with 2 interventional visits (complete blood samples will be collected) at baseline and at 8 weeks. In order to be included in the trial, the patient must read the Patient Information Sheet and sign the informed consent form. The dosage regimen is two capsules per day in a single dose.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedFeb 8, 2024
Enrollment StartApr 19, 2022
Primary CompletionJul 11, 2022
Study CompletionOct 1, 2022
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 2.4 years ago

Interventions

Inmunoferondietary

The dosage regimen is two capsules (with the active ingredients) per day in a single dose.The study lasted 8 weeks, with 2 interventional visits at baseline and at 8 weeks. Blood samples are collected twice: once on day 0 of the study and again at the final visit.

Placebodietary

The dosage regimen is two capsules (with inert ingredients) per day in a single dose.The study lasted 8 weeks, with 2 interventional visits at baseline and at 8 weeks. Blood samples are collected twice: once on day 0 of the study and again at the final visit.